Michael Ulz

Stock Analyst at Baird

(1.59)
# 1615
Out of 5,386 analysts
164
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:
45 Stocks
Name Action PT Current % Upside Ratings Updated
KPTI Karyopharm Therapeut...
Maintains: Outperform
54 42
4.36 863.3% 6 May 13, 2025
SLN Silence Therapeutics
Maintains: Overweight
45 25
5.81 330.29% 12 May 9, 2025
VKTX Viking Therapeutics
Maintains: Overweight
105 102
26.53 284.47% 3 Apr 24, 2025
ALNY Alnylam Pharmaceutic...
Maintains: Equal-Weight
284 268
322.64 -16.94% 10 Apr 11, 2025
KYTX Kyverna Therapeutics
Maintains: Overweight
40 20
3.28 509.76% 2 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
30 22
1.58 1292.41% 6 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
29
13.15 120.53% 1 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
11 7
4.74 47.68% 7 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 20
1.71 1069.59% 4 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
20 5
5.43 -7.92% 5 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
18 10
1.68 495.24% 2 Feb 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
46 96
56.13 71.03% 4 Jan 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
48 52
9.59 442.23% 2 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
110 115
128.07 -10.21% 9 Jul 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
53 57
51.02 11.72% 3 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
36 27
16.06 68.12% 4 May 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
47 65
n/a n/a 4 Apr 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
3 7
1.03 579.61% 8 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
23 12
n/a n/a 4 Jan 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
45 48
39.83 20.51% 4 Nov 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 27
10.32 161.63% 2 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
42 37
n/a n/a 9 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
35 40
n/a n/a 4 May 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
30 20
2.14 834.58% 3 Mar 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
45
2.52 1685.71% 1 Feb 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
20 10
0.69 1349.28% 3 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
6 8
n/a n/a 5 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
3
2.4 25% 1 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
18 30
5.16 481.4% 1 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
135 90
n/a n/a 3 Aug 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
15 7
n/a n/a 3 May 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
25 30
1.13 2554.87% 3 Mar 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
n/a
n/a n/a 1 Feb 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
84 36
n/a n/a 2 Jan 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
45
9.96 351.81% 1 Oct 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
500
n/a n/a 1 Sep 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
12 20
n/a n/a 2 May 28, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
30
n/a n/a 1 Apr 16, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
3 1
n/a n/a 4 Mar 29, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 4
n/a n/a 3 Oct 22, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
17 0
n/a n/a 2 Sep 21, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
680 544
n/a n/a 2 Jun 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
85 80
36.51 119.12% 2 Nov 3, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
12 15
5.94 152.53% 3 Jul 12, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
127 182
n/a n/a 2 Feb 27, 2017